The management of upper airway diseases: an ongoing challenge for the clinician.
J Biol Regul Homeost Agents
; 35(1 Suppl. 2): 1-2, 2021.
Article
in English
| MEDLINE | ID: covidwho-1227256
ABSTRACT
Upper airway diseases are widespread in clinical practice. However, some aspects are still debated. The current supplement presents and discusses the most common disorders encountered in daily medical activity. The COVID-19 dramatic pandemic requires an urgent solution. Promising non-pharmacological agents are discussed. Chronic diseases are frequent in childhood, so to know risk factors is useful in their management. Allergic rhinitis and chronic rhinosinusitis should be treated with anti-inflammatory drugs, but complementary compounds should be alternated to preserve health. Empty nose syndrome is a frequent complication of nasal surgery and requires adequate staging and hydrating procedure. Lastly, laryngopharyngeal reflux is an intriguing challenge for the clinician. Alginates represent a safe and effective way to relieve LPR symptoms.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Sinusitis
/
Rhinitis
/
COVID-19
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Biol Regul Homeost Agents
Journal subject:
Biology
/
Biochemistry
Year:
2021
Document Type:
Article
Affiliation country:
21-1supp2-1
Similar
MEDLINE
...
LILACS
LIS